The Eve Appeal
Gynaecological cancers are the world's fourth largest cancer killer of women.
Every year a million women are diagnosed with a gynaecological cancer worldwide.
In the UK, 18,000 women are diagnosed and nearly 7,500 women die every year. And yet, awareness and funding of gynaecological cancers remains low.
The Eve Appeal is determined to change this by funding vital research focused on developing effective methods of prediction, detection, treatment and care that will help save women's lives not only in the UK but throughout the world.
This world-leading research is complicated and challenging but our vision is simple:
A future where fewer women develop and more women survive gynaecological cancers.
What We Do
Since its inception, The Eve Appeal has worked hard to raise money to fund the groundbreaking research programme now under way at the UCL Gynaecology Cancer Research Centre at the Institute for Women's Health - vital and much-needed research that will benefit women in the UK and worldwide.
A report by an independent panel reviewing the Research Centre's work and progress (the Pattison Review Report 2009) acknowledges the importance of The Eve Appeal's role, "The Appeal has consistently contributed about 15% of the total research income.
"However its contributions have been disproportionately important because they have pump-primed new projects, supported highly innovative work and covered gaps in funding allowing projects to maintain momentum. The national and international standing of the projects to which it has contributed is testament to the effectiveness of The Eve Appeal support."
Major breakthroughs are already being achieved towards the Research Centre's aims to improve survival rates of women with gynaecological cancers through screening, early diagnosis and risk prediction.